Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu. (Q27851719)
Jump to navigation
Jump to search
scientific article
- Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu. |
scientific article |
|
Statements
2 references
Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu (English)
E Teugels
C Geers
L Decoster
D Galdermans
J De Mey
H Everaert
P In't Veld
10 February 2012
Identifiers
2 references
2 references